87174009: Guaifenesin (substance)

SNOMED CT Concept\Substance\...

\Drug or medicament (substance)\Respiratory system agent (substance)\Cough/decongestant preparation\Expectorant agent\Guaifenesin

\Substance categorised by structure\Chemical\Chemical categorized by structure\Organic compound\Substance with ether structure (substance)\Methyl ether (substance)\Guaifenesin

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2002. Module: SNOMED CT core

Descriptions:

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Guaifenesin	Is a	Medicinal product acting as expectorant agent (product)	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin	Is a	Expectorant agent	true	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin	Is a	Guaifenesin and derivatives	false	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin	Is a	Methyl ether (substance)	true	Inferred relationship	Existential restriction modifier (core metadata concept)

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Guaifenesin measurement (procedure)	Has measured component	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin measurement (procedure)	Component	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 50mg/1mL	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 400mg/10 mL liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 800 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 100mg/5mL oral liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 300 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 50 milligram/1 milliliter conventional release oral solution (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 575 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + oxtriphylline 50mg/100mg	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + oxtriphylline 50mg/100mg elixir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline, anhydrous 90mg/150mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 100mg/5ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Siltussin sa 100mg/5ml syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 1200mg m/r tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 300mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin poisoning	Causative agent (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Accidental guaifenesin poisoning	Causative agent (attribute)	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Intentional guaifenesin poisoning	Causative agent (attribute)	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
intoxication par la guaïfénésine d'intention indéterminée	Causative agent (attribute)	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Brompheniramine maleate + guaifenesin + hydrocodone bitartrate 2mg/200mg/5mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg elixir	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/100mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 100mg/50mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline + guaifenesin 200mg/100mg capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride + guaifenesin 6.25mg/100mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 100mg/150mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 100mg/80mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 200mg/150mg solution	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline 90mg/150mg syrup	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin + theophylline sodium glycinat 100mg/300mg elixir (product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Dyphylline+guaifenesin 100mg/100mg liquid	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing precisely ephedrine sulfate 25 milligram and guaifenesin 400 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 12.5 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Ephedrine hydrochloride 25 mg and guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing choline theophyllinate and guaifenesin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Diprophylline- and guaifenesin-containing product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing guaifenesin and theophylline (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dextromethorphan and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Guaifenesin 600mg m/r/dextromethorphan 30mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 1200mg m/r/dextromethorphan 60mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing guaifenesin and hydrocodone (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing codeine and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing codeine and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing chlorphenamine and guaifenesin and hydrocodone and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Product containing guaifenesin and phenylephrine and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing guaifenesin and phenylephrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dextromethorphan and guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Product containing guaifenesin and phenylpropanolamine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing dextromethorphan and guaifenesin and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	3
Pseudoephedrine + guaifenesin	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Product containing dexbrompheniramine and guaifenesin and paracetamol and pseudoephedrine (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	4
Guaifenesin 1200mg m/r/pseudoephedrine 120mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Guaifenesin 600mg m/r/pseudoephedrine 60mg tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)
Accidental guaifenesin poisoning	Causative agent (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Intentional guaifenesin poisoning	Causative agent (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing cetylpyridinium and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing ephedrine and guaifenesin (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 1.2 gram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 800 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 800 mg oral tablet	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 300 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 300 mg oral capsule	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 1 g oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 1 g oral tablet	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 675 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 575 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 575 mg oral tablet	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 200 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 200 mg oral tablet	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 600 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely diprophylline 100 milligram and guaifenesin 100 milligram/1 each conventional release oral tablet (clinical drug)	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Dyphylline + guaifenesin 200mg/100mg capsule	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Diprophylline 200 mg and guaifenesin 200 mg oral tablet	Has basis of strength substance (attribute)	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Product containing precisely guaifenesin 183 milligram and theophylline 305 milligram/1 each conventional release oral capsule (clinical drug)	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Guaifenesin 91.44 mg and theophylline 152.4 mg oral capsule	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	2
Guaifenesin 100 mg oral tablet	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 100 mg oral tablet	Has basis of strength substance (attribute)	True	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1
Guaifenesin 200 mg oral capsule	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Guaifenesin	Inferred relationship	Existential restriction modifier (core metadata concept)	1

Page 1 of 3 Next End

This concept is not in any reference sets

Back to Start

Id	Description	Lang	Type	Status	Case?	Module
144553013	Guaifenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144555018	Glyceryl guaiacolate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144556017	Guaianesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
829592015	Guaifenesin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2989358018	Guaiphenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3700273012	Alpha-glyceryl guaiacol ether	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144553013	Guaifenesin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
144553013	Guaifenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144554019	alpha-Glyceryl guaiacol ether	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
144555018	Glyceryl guaiacolate	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
144555018	Glyceryl guaiacolate	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
144556017	Guaianesin	en	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT core
144556017	Guaianesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
829592015	Guaifenesin (substance)	en	Fully specified name	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
829592015	Guaifenesin (substance)	en	Fully specified name	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
2989358018	Guaiphenesin	en	Synonym (core metadata concept)	Active	Only initial character case insensitive (core metadata concept)	SNOMED CT core
2989358018	Guaiphenesin	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
3700273012	Alpha-glyceryl guaiacol ether	en	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT core
50211000195117	guaifenesina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64361000195114	Guaifenesin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
234351000195112	Guajacolglycerolether	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
861291000172119	guaïfénésine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
861291000172119	guaïfénésine	fr	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
50211000195117	guaifenesina	it	Synonym (core metadata concept)	Active	Entire term case insensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
64361000195114	Guaifenesin	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module
234351000195112	Guajacolglycerolether	de	Synonym (core metadata concept)	Active	Entire term case sensitive (core metadata concept)	SNOMED CT Switzerland NRC maintained Module